U.S. federal trademark · Serial No. 79268012 · Reg. No. 6171861
Scientific research for medical and veterinary purposes, in particular for treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders, using liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or emulsions
Medical and veterinary services in connection with cancer diseases, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders
Chemical reagents for medical and veterinary purposes; Medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleid acids for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of the active ingredients for pharmaceuticals for use in the treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.